CHLORDIAZEPOXIDE-CLIDINIUM (chlordiazepoxide/clidinium bromide)
BENZODIAZEPINES · ADJUNCT THERAPY FOR ACUTE ENTEROCOLITIS ·+2
ASCEND LABORATO
Drug class
Benzodiazepines-Non-Injectable Formulations (oral etc.)
Rather than representing a distinct formal pharmacological category, "Benzodiazepines-Non-Injectable Formulations (oral etc.)" is an administrative and formulary classification that encompasses enteral and non-parenteral dosage forms of benzodiazepines, such as oral tablets, capsules, and solutions. Read more about Benzodiazepines-Non-Injectable Formulations (oral etc.)
242 drugs in this class 93 manufacturers
Drugs in Benzodiazepines-Non-Injectable Formulations (oral etc.)
CLOBAZAM
ANTICONVULSANTS · LENNOX-GASTAUT SYNDROME TREATMENT ADJUNCT
ASCEND LABORATO
DIAZEPAM
BENZODIAZEPINES · ALCOHOL WITHDRAWAL SYNDROME ·+4
PRECISION DOSE
MIDAZOLAM HCL
BENZODIAZEPINES · INDUCE ANTEROGRADE AMNESIA ·+4
PRECISION DOSE
DIAZEPAM
ANTICONVULSANTS · ACUTE REPETITIVE SEIZURES
LUPIN PHARMACEU
TRIAZOLAM
BENZODIAZEPINES · INSOMNIA
ZYDUS PHARMACEU
CLORAZEPATE DIPOTASSIUM
BENZODIAZEPINES · ALCOHOL WITHDRAWAL SYNDROME ·+2
NOVITIUM PHARMA
ALPRAZOLAM
BENZODIAZEPINES · ANXIETY ·+3
APHENA PHARMA S
CLONAZEPAM
ANTIANXIETY AGENTS · PANIC DISORDER ·+4
APHENA PHARMA S
Filter & compare in the drug finder →
Opens the drug finder with Benzodiazepines-Non-Injectable Formulations (oral etc.) preselected. Add indication or manufacturer filters there.
Rather than representing a distinct formal pharmacological category, "Benzodiazepines-Non-Injectable Formulations (oral etc.)" is an administrative and formulary classification that encompasses enteral and non-parenteral dosage forms of benzodiazepines, such as oral tablets, capsules, and solutions.
Agents in this class act as positive allosteric modulators of gamma-aminobutyric acid type A ($\text{GABA}_\text{A}$) receptors in the central nervous system, enhancing inhibitory neurotransmission to produce anxiolytic, sedative, anticonvulsant, and muscle-relaxant effects.
In clinical practice, these non-injectable formulations are primarily indicated for the management of generalized anxiety disorders, panic disorder, insomnia, seizure disorders, and acute alcohol withdrawal symptoms.
-
mo.gov
Rather than representing a distinct formal pharmacological category, "Benzodiazepines-Non-Injectable Formulations (oral etc.)" is an administrative and formulary classification that encompasses enteral and non-parenteral dosage forms of benzodiazepines, such as oral tablets, capsules, and solutions
-
formularynavigator.com
Rather than representing a distinct formal pharmacological category, "Benzodiazepines-Non-Injectable Formulations (oral etc.)" is an administrative and formulary classification that encompasses enteral and non-parenteral dosage forms of benzodiazepines, such as oral tablets, capsules, and solutions
-
nih.gov
Agents in this class act as positive allosteric modulators of gamma-aminobutyric acid type A ($\text{GABA}_\text{A}$) receptors in the central nervous system, enhancing inhibitory neurotransmission to produce anxiolytic, sedative, anticonvulsant, and muscle-relaxant effects In clinical practice, these non-injectable formulations are primarily indicated for the management of generalized anxiety disorders, panic disorder, insomnia, seizure disorders, and acute alcohol withdrawal symptoms
-
nih.gov
Agents in this class act as positive allosteric modulators of gamma-aminobutyric acid type A ($\text{GABA}_\text{A}$) receptors in the central nervous system, enhancing inhibitory neurotransmission to produce anxiolytic, sedative, anticonvulsant, and muscle-relaxant effects In clinical practice, these non-injectable formulations are primarily indicated for the management of generalized anxiety disorders, panic disorder, insomnia, seizure disorders, and acute alcohol withdrawal symptoms
-
nih.gov
Agents in this class act as positive allosteric modulators of gamma-aminobutyric acid type A ($\text{GABA}_\text{A}$) receptors in the central nervous system, enhancing inhibitory neurotransmission to produce anxiolytic, sedative, anticonvulsant, and muscle-relaxant effects In clinical practice, these non-injectable formulations are primarily indicated for the management of generalized anxiety disorders, panic disorder, insomnia, seizure disorders, and acute alcohol withdrawal symptoms
-
nih.gov
In clinical practice, these non-injectable formulations are primarily indicated for the management of generalized anxiety disorders, panic disorder, insomnia, seizure disorders, and acute alcohol withdrawal symptoms
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.